Cargando…

Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South

BACKGROUND: The Southern United States is disproportionately affected by HIV with the city of New Orleans ranking second for HIV incidence. Our clinic is committed to overcoming this disparity by optimizing the HIV care continuum. Recent studies have shown that immediate linkage to care and access t...

Descripción completa

Detalles Bibliográficos
Autores principales: Halperin, Jason, Holm, Pam, Butler, Isolde, Conner, Katherine, Van Sickels, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631021/
http://dx.doi.org/10.1093/ofid/ofx163.1117
_version_ 1783269349732122624
author Halperin, Jason
Holm, Pam
Butler, Isolde
Conner, Katherine
Van Sickels, Nicholas
author_facet Halperin, Jason
Holm, Pam
Butler, Isolde
Conner, Katherine
Van Sickels, Nicholas
author_sort Halperin, Jason
collection PubMed
description BACKGROUND: The Southern United States is disproportionately affected by HIV with the city of New Orleans ranking second for HIV incidence. Our clinic is committed to overcoming this disparity by optimizing the HIV care continuum. Recent studies have shown that immediate linkage to care and access to antiretroviral treatment improves the health of people living with HIV and has the added public health benefit of reducing HIV transmission. Our Ryan White-funded FQHC initiated a test-and-start strategy linking newly diagnosed patients with a treating provider and starting ART within 72 hours of HIV diagnosis. METHODS: Patients newly diagnosed with HIV at one of our community based testing sites or by referral were linked to an ART-prescribing provider by a linkage to care specialist. Patients were assessed for readiness to begin ART and labs were drawn on day of visit. A 30-day supply of TAF/FTC and DTG are provided to patients and funded through Ryan White Part A in collaboration with our city’s office of health policy. This regimen was chosen to overcome the risk of transmitted resistance. Patients were evaluated and enrolled in insurance services within this 30-day period. RESULTS: Between December 2016 – March 2017, 35 patients were referred for rapid start. 32 patients were linked to care within 72 hours of diagnosis. The median age of patient was 26 with 81% identifying as male, 78% were MSM and 56% African-American. 75% were linked within 24 hours of diagnosis. 50% had a concurrent STI. 38% were uninsured. By 120 days post-diagnosis, 31/32 patients were virally suppressed with 78% within 60 days post diagnosis. 12/16 of the uninsured patients were enrolled in active insurance within 30 days and the remaining were enrolled in Ryan White Services. CONCLUSION: A test-and-start strategy of linkage and initiation of medications within 72 hours is feasible and highly effective in a Ryan-White funded clinic in the Southern United States. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631021
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56310212017-11-07 Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South Halperin, Jason Holm, Pam Butler, Isolde Conner, Katherine Van Sickels, Nicholas Open Forum Infect Dis Abstracts BACKGROUND: The Southern United States is disproportionately affected by HIV with the city of New Orleans ranking second for HIV incidence. Our clinic is committed to overcoming this disparity by optimizing the HIV care continuum. Recent studies have shown that immediate linkage to care and access to antiretroviral treatment improves the health of people living with HIV and has the added public health benefit of reducing HIV transmission. Our Ryan White-funded FQHC initiated a test-and-start strategy linking newly diagnosed patients with a treating provider and starting ART within 72 hours of HIV diagnosis. METHODS: Patients newly diagnosed with HIV at one of our community based testing sites or by referral were linked to an ART-prescribing provider by a linkage to care specialist. Patients were assessed for readiness to begin ART and labs were drawn on day of visit. A 30-day supply of TAF/FTC and DTG are provided to patients and funded through Ryan White Part A in collaboration with our city’s office of health policy. This regimen was chosen to overcome the risk of transmitted resistance. Patients were evaluated and enrolled in insurance services within this 30-day period. RESULTS: Between December 2016 – March 2017, 35 patients were referred for rapid start. 32 patients were linked to care within 72 hours of diagnosis. The median age of patient was 26 with 81% identifying as male, 78% were MSM and 56% African-American. 75% were linked within 24 hours of diagnosis. 50% had a concurrent STI. 38% were uninsured. By 120 days post-diagnosis, 31/32 patients were virally suppressed with 78% within 60 days post diagnosis. 12/16 of the uninsured patients were enrolled in active insurance within 30 days and the remaining were enrolled in Ryan White Services. CONCLUSION: A test-and-start strategy of linkage and initiation of medications within 72 hours is feasible and highly effective in a Ryan-White funded clinic in the Southern United States. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631021/ http://dx.doi.org/10.1093/ofid/ofx163.1117 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Halperin, Jason
Holm, Pam
Butler, Isolde
Conner, Katherine
Van Sickels, Nicholas
Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South
title Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South
title_full Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South
title_fullStr Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South
title_full_unstemmed Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South
title_short Linkage and Anti-Retroviral Therapy Within 72-hours at a Ryan White-Funded FQHC in the Deep South
title_sort linkage and anti-retroviral therapy within 72-hours at a ryan white-funded fqhc in the deep south
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631021/
http://dx.doi.org/10.1093/ofid/ofx163.1117
work_keys_str_mv AT halperinjason linkageandantiretroviraltherapywithin72hoursataryanwhitefundedfqhcinthedeepsouth
AT holmpam linkageandantiretroviraltherapywithin72hoursataryanwhitefundedfqhcinthedeepsouth
AT butlerisolde linkageandantiretroviraltherapywithin72hoursataryanwhitefundedfqhcinthedeepsouth
AT connerkatherine linkageandantiretroviraltherapywithin72hoursataryanwhitefundedfqhcinthedeepsouth
AT vansickelsnicholas linkageandantiretroviraltherapywithin72hoursataryanwhitefundedfqhcinthedeepsouth